Skip to main content

BillionToOne, Inc.

corporate_fare Company Profile

BillionToOne, Inc.

BLLN·NASDAQ·Life Sciences·CIK 0002070849

BillionToOne is a company that transforms healthcare through molecular diagnostics. The company uses a single molecule next-generation sequencing (smNGS) platform to detect and precisely quantify genetic targets with single-molecule sensitivity. This technology uses patented Quantitative Counting Templates (QCTs) to measure at the physical limit of detection, which is the single DNA molecule. This addresses the challenge of detecting sparse disease signals in cell-free DNA (cfDNA). BillionToOne's technology platform supports prenatal and oncology products, which provide insights from blood draws to aid in disease diagnosis and treatment. The company's smNGS platform technologies, combined with an AI-enhanced integrated workflow, aim to advance non-invasive liquid biopsy. BillionToOne transitioned from an R&D-focused company to a commercial organization. In 2019, the company launched UNITY, its first prenatal product. UNITY is a non-invasive prenatal test (NIPT) that uses cfDNA to assess fetal risk for recessive conditions like sickle cell disease and cystic fibrosis without needing a paternal sample or invasive procedures such as amniocentesis. BillionToOne has become a leader in the prenatal testing market, based on revenue and American College of Obstetricians and Gynecologists (ACOG) practice advisory guidelines, and has expanded its UNITY offering to cover comprehensive prenatal genetic needs from a single maternal blood draw.

BillionToOne, Inc. (NASDAQ:BLLN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for BLLN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for BLLN spans 10-Q, 8-K, 10-K, SCHEDULE 13D.

Recent high-impact activity:

  • BillionToOne Rejects Short Seller's Claims, Weighs Legal Action
  • Fuzzy Panda Short Report Sends BillionToOne Down 10%
  • BillionToOne 10-Q: Q3 Revenue $123.0M, Profit $17.4M, Material Weaknesses Persist
  • BillionToOne Beats on Q3 Revenue, Lifts 2026 Outlook to $460-470M
  • Peer-Reviewed Study Shows BillionToOne's Tissue-Free Assay Matches or Beats Tumor-Informed Monitoring

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$305.11M
Net Income
$7.45M
Diluted EPS
$0.14
Op. Cash Flow
$24.59M
Free Cash Flow
$15.71M
Gross Profit
$208.46M
Operating Income
$16.02M
Cash & Equivalents
$495.98M
Total Debt
$57.23M
Debt / Equity
0.12×
Net Margin
2.4%
Shares Outstanding
15.88M sh
Source: 10-K · filed 2026-03-11 · accession 0002070849-26-000017

Short Interest & Short Volume

6.69 days to cover

FINRA reported short interest of 2,970,311 shares in BLLN as of the October 30, 2026 settlement, a 1.3% increase from the prior period — about 6.7 days to cover at its recent average daily volume. On November 20, 2026, 61.8% of BLLN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,970,311 shares as of October 30, 2026
Change vs prior period▲ 1.3%
Days to cover6.69 at avg daily volume of 444,161
Daily short volume (FINRA facilities)61.8% of 396,996 shares on November 20, 2026
5-day average short volume60.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with B →
$89.92
52-week range · as of 2026-11-04 $61.96 – $150.44
Market cap
$4.3B
Volume
819.5K (1.2× avg)
3-mo avg 662.2K
Live data · 2026-11-22 03:42 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BLLN - Latest Insights

BLLN
Nov 18, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $91.54
Real-time Price: $89.92 info
Change: -$1.62 (-2%) info
Market Cap: $4.296B info
BLLN
Nov 18, 2026, 9:38 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $87.83
Real-time Price: $89.92 info
Change: +$2.09 (+2%) info
Market Cap: $4.296B info
BLLN
Nov 04, 2026, 4:47 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.00
Real-time Price: $89.92 info
Change: -$23.08 (-20%) info
Market Cap: $4.296B info
BLLN
Nov 04, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $119.49
Real-time Price: $89.92 info
Change: -$29.57 (-25%) info
Market Cap: $4.296B info
BLLN
Oct 07, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $99.87
Real-time Price: $89.92 info
Change: -$9.95 (-10%) info
Market Cap: $4.296B info
BLLN
Aug 05, 2026, 4:42 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.35
Real-time Price: $89.92 info
Change: -$23.43 (-21%) info
Market Cap: $4.296B info
BLLN
Aug 05, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $106.38
Real-time Price: $89.92 info
Change: -$16.46 (-15%) info
Market Cap: $4.296B info
BLLN
Jun 29, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $120.40
Real-time Price: $89.92 info
Change: -$30.48 (-25%) info
Market Cap: $4.296B info
BLLN
May 06, 2026, 4:43 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $80.00
Real-time Price: $89.92 info
Change: +$9.92 (+12%) info
Market Cap: $4.296B info
BLLN
May 06, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $80.00
Real-time Price: $89.92 info
Change: +$9.92 (+12%) info
Market Cap: $4.296B info
BLLN
Mar 11, 2026, 4:55 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $69.40
Real-time Price: $89.92 info
Change: +$20.52 (+30%) info
Market Cap: $4.296B info
BLLN
Mar 04, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $85.01
Real-time Price: $89.92 info
Change: +$4.91 (+6%) info
Market Cap: $4.296B info
BLLN
Mar 04, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $80.50
Real-time Price: $89.92 info
Change: +$9.42 (+12%) info
Market Cap: $4.296B info
BLLN
Jan 20, 2026, 7:46 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $85.95
Real-time Price: $89.92 info
Change: +$3.97 (+5%) info
Market Cap: $4.296B info
BLLN
Jan 12, 2026, 8:09 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $85.94
Real-time Price: $89.92 info
Change: +$3.98 (+5%) info
Market Cap: $4.296B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets